Matthew R Plooster - Net Worth and Insider Trading
Matthew R Plooster Net Worth
The estimated net worth of Matthew R Plooster is at least $13,721 dollars as of 2024-11-13. Matthew R Plooster is the Director of Zevra Therapeutics Inc and owns about 1,601 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $13,721. Details can be seen in Matthew R Plooster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew R Plooster has not made any transactions after 2023-03-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew R Plooster
Matthew R Plooster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew R Plooster owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Matthew R Plooster’s form 4 insider trades.
Insider Ownership Summary of Matthew R Plooster
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | director |
Matthew R Plooster Latest Holdings Summary
Matthew R Plooster currently owns a total of 1 stock. Matthew R Plooster owns 1,601 shares of Zevra Therapeutics Inc (ZVRA) as of March 9, 2023, with a value of $13,721.
Latest Holdings of Matthew R Plooster
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | 1,601 | 8.57 | 13,721 |
Holding Weightings of Matthew R Plooster
Matthew R Plooster Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew R Plooster has made a total of 2 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 11,000 shares on March 9, 2023, which cost Matthew R Plooster around $46,200.
Insider Trading History of Matthew R Plooster
- 1
Matthew R Plooster Trading Performance
GuruFocus tracks the stock performance after each of Matthew R Plooster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew R Plooster is 23.98%. GuruFocus also compares Matthew R Plooster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew R Plooster within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew R Plooster's insider trading performs compared to the benchmark.
Performance of Matthew R Plooster
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.07 | | | | | |
| Relative Return to S&P 500(%) | 11.86 | | | | | |
Matthew R Plooster Ownership Network
Ownership Network List of Matthew R Plooster
Ownership Network Relation of Matthew R Plooster
Matthew R Plooster Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Matthew R Plooster is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Matthew R Plooster made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 1,500 shares made by Watton Corey Michael , a net purchase of 30,000 shares made by John B Bode , and a net purchase of 5,740 shares made by R. Laduane Clifton .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 58,740 shares were bought by its insiders, resulting in a net purchase of 58,740 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Matthew R Plooster Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew R Plooster. You might contact Matthew R Plooster via mailing address: 2656 Crosspark Road, Suite 100, Coralville Ia 52241.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
